GOP’s Obamacare replacement plans would provide less financial help, analyses show

WASHINGTON — As congressional Republicans move to solidify their Obamacare repeal-and-replace legislation, concern is mounting that their strategies will leave millions of Americans with less financial assistance and more expensive coverage. A new analysis on Wednesday from the Kaiser Family…

Pharma firm CEO insists $89,000 drug is affordable, but what’s the true cost?

CHICAGO — When Marathon Pharmaceuticals’ $89,000 price tag for a year’s supply of its newly approved muscular dystrophy drug sparked outrage earlier this month, the company’s CEO responded with another figure: $20. That’s how much he expected Duchenne muscular dystrophy…